Born to Run? Little Ones Get Test for Sports Gene New York Times, United States - Nov 29, 2008 Dr. Theodore Friedmann, the director of the University of California-San Diego Medical Center?s interdepartmental gene therapy program, called it ?an ...
Researcher to lecture in Palm Springs on AIDS therapy The Desert Sun, CA - The donor marrow had a rare, but naturally occurring genetic mutation which made it resistant to almost all strains of HIV, apparently killing any remaining ...
Doctors, researchers on quest for a cure News-Herald.com, OH - Nov 28, 2008 In addition to refining old treatments, cell and gene therapy have opened a lot of possibilities in cancer treatment. By manipulating genes or cells, ...
Blame your genes for lengthy illness The Age, Australia - The study, published in the journal Clinical Infectious Diseases, is the first to explore the genetic determinants of the severity of sickness. ...
Genetic tests rise and staff struggle Sydney Morning Herald, Australia - Tests on family members of people with cancer-causing gene mutations accounted for 5 per cent. Chromosome tests on unborn children and DNA testing of ...
Breast cancer: What you need to know Food Consumer, IL - Eating French Fries May Raise Breast Cancer Risk. Weight loss: A study indicates that women with a mutation in the gene BRCA1, which predisposes women to ...
A Second Chance to Buy Wyeth? Barron's - Aug 3, 2008 The drug is designed not simply to treat symptoms of the disease, but to actually slow its progression. But on news of the results, shares of both companies ...
Genetic testing brings new hopes, hard choices Boston Globe, United States - Aug 3, 2008 And, as in the case of hypertrophic cardiomyopathy, it holds out the promise that in the future, gene tests will predict far better who will get a disease, ...
Wellcome Trust Genotyping Study Using Agilent Arrays GenomeWeb News (subscription), NY - ...disease, ankylosing spondylitis, multiple sclerosis, and breast cancer. Agilent said that genetic samples will be processed by Oxford Gene Technology, ...A
Gene expression profiling predicts clinical outcome of breast cancer - LJ van't Veer, H Dai, MJ van de Vijver, YD He, AAM … - Nature, 2002 - Mass Med Soc ... biotechnology company used DNA microarray ("gene fingerprint") technology to study
98 primary breast tumors excised ... years, and others remained disease-free for ...
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer - MJ van de Vijver, YD He, LJ van't Veer, H Dai, AAM … - New England Journal of Medicine, 2002 - content.nejm.org ... Conclusions The gene-expression profile we studied is a more powerful predictor
of the outcome of disease in young patients with breast cancer than standard ...
Identification of the breast cancer susceptibility gene BRCA2. - R Wooster, G Bignell, J Lancaster, S Swift, S Seal … - Nature, 1995 - ncbi.nlm.nih.gov ... at a young age, are attributable to a highly penetrant, autosomal dominant
predisposition to the disease. The breast cancer susceptibility gene, BRCA2, was ...
Xenograft Model of Progressive Human Proliferative Breast Disease - FR Miller, HD Soule, L Tait, RJ Pauley, SR Wolman, … - jnci, 1993 - jnci.oxfordjournals.org ... from spontaneous immortalization of breast epithelial cells ... from a patient with
fibrocystic disease, and cell ... with the neomycin-resistance gene and either the ...
HER-2/neu (c-erb-B2) gene and protein in breast cancer. - JS Ross, JA Fletcher - Am J Clin Pathol, 1999 - ncbi.nlm.nih.gov ... in situ hybridization assays designed to detect HER-2/neu gene amplification are ...
in situ, and HER-2/neu protein status in uncommon breastdiseases in female ...
Scientists are developing a new gene therapy designed to stop breast cancer spreading. The treatment involves using a genetically modified virus to stop tumours migrating.
So far, experiments have been conducted only on human cancer cells in the laboratory.
But scientists at Cancer Research UK (CRUK) believe the therapy could be a breakthrough in the treatment of breast cancer, the most common form of the disease in Britain, which affects one in ten women.
Gene therapy silences faulty genes responsible for genetic defects, or switches on genes to help suppress illnesses.
One way of doing this is to use a virus, such as the one that causes the common cold, engineered to be harmless.
Experts at CRUK, working with a team at King's College, London, say that treating women with the virus before surgery may in the future hold cancer cells in place within the tumour, improving the chances of a successful operation.
